Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)
Arterial Obstructive Diseases, Coronary Disease
About this trial
This is an interventional prevention trial for Arterial Obstructive Diseases focused on measuring Platelets, Platelet Aggregation Inhibitors, Protease-Activated Receptor 1, Hemorrhage
Eligibility Criteria
Inclusion Criteria: A person who is 45 years or older and is mentally competent to provide a signed written informed consent. A person who is scheduled to undergo a percutaneous coronary intervention or a heart catheterization with the intent to undergo a percutaneous coronary intervention. If a woman is of childbearing potential (ie, before menopause), she must test negative for pregnancy and agree to use a reliable method of birth control. Exclusion Criteria: Pregnancy Recent stroke Active internal bleeding or a history of a bleeding disorder Increased risk of bleeding Severe high blood pressure Liver or kidney disease Low platelet count Condition such as alcoholism, mental illness, or drug dependence Ongoing chest pain Planned or ongoing treatment with a blood thinning medication A serious condition or illness that would interfere with participation in the study